Recent Company News

• 02:54 PM ET Oct 01, 2025
  

  Santen Pharmaceutical repurchased 2.8M shares during September (¥1642.0000, 0)

• 01:03 PM ET Sep 26, 2025
  

  StreetAccount Activist Summary: Week of 22-Sep

• 02:05 AM ET Sep 22, 2025
  

  Santen Pharmaceutical holder Silchester International Investors raises stake to 7.10% from (¥1655.0000, +5)

• 08:05 AM ET Sep 18, 2025
  

  Kairos Pharma announces positive interim efficacy analysis of phase 2 trial of ENV105 ($1.68, 0.00)

• 10:58 PM ET May 21, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 07:26 PM ET Aug 07, 2025
  

  Santen Pharmaceutical downgraded to hold from buy at Jefferies (¥1665.0000, 0)

• 02:59 AM ET Aug 07, 2025
  

  Santen Pharmaceutical reports Q1 core net income attributable ¥7.64B vs FactSet ¥8.11B (¥1665.0000, 0)

• 09:10 PM ET May 21, 2025
  

  Santen Pharmaceutical forms medium-tern plan for FY25-29: targets Core operating profit ¥80B in FY29 (21-May post-Japan close) (¥1570.5000, +47)